SXTC (SXTC) Stock Price & Analysis
SXTC (SXTC) rose 0.65% to USD 1.56 as of June 10, 2026 at 03:10 UTC, according to Nexqual real-time market data.
SXTC last closed at USD 1.55; the session ranged USD 1.54–1.68 on volume of 131,707 shares. Market capitalization is $6.95M, with a 52-week range of USD 1.25–1,047 (NCM). Source: Nexqual, June 10, 2026 at 03:10 UTC.
Key Statistics (as of June 10, 2026 at 03:10 UTC)
| Price | USD 1.56 |
|---|---|
| Change | ▲ 0.65% (up) |
| Previous Close | USD 1.55 |
| Open | USD 1.55 |
| Day Range | USD 1.54 – 1.68 |
| 52-Week Range | USD 1.25 – 1,047 |
| Volume | 131,707 shares |
| Market Cap | $6.95M |
| Exchange | NCM |
Technical Analysis (SXTC)
Nexqual's technical model rates SXTC "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 03:10 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 40.72 (neutral) |
| vs SMA50 | Below (USD 1.83) |
| MACD | -0.17 (negative) |
Analyst Ratings (SXTC)
Wall Street analysts rate SXTC "None", per Nexqual as of June 10, 2026 at 03:10 UTC.
| Consensus Rating | None |
|---|
Earnings (SXTC)
Source: Nexqual, June 10, 2026 at 03:10 UTC.
Financials & Fundamentals (SXTC)
| Total Revenue | $1.54M |
|---|---|
| Revenue Growth (YoY) | -24.50% |
| Gross Margin | +21.74% |
| Operating Margin | -1011.69% |
| Profit Margin | +0.00% |
| ROE | -50.30% |
| Debt / Equity | 5.95 |
| Current Ratio | 4.37 |
| Total Cash | $21.31M |
| Total Debt | $1.20M |
| Free Cash Flow | $-1.95M |
Source: Nexqual, June 10, 2026 at 03:10 UTC.
Financial Health Score (SXTC)
Nexqual rates SXTC's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 03:10 UTC.
| Growth | Critical — Revenue -25% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Strong — $21M cash vs $1M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$2M, burning cash |
| Efficiency | Critical — ROE -50%, ROA -18.3% |
Ownership (SXTC)
| Insider Ownership | +0.71% |
|---|---|
| Institutional Ownership | +0.21% |
| Shares Outstanding | 4.46M |
| Float | 740,787 |
| Short % of Float | +0.12% |
Source: Nexqual, June 10, 2026 at 03:10 UTC.
Leadership (SXTC)
SXTC is led by Feng Zhou (age 33), Chairman of the Board & Co-CEO, per Nexqual as of June 10, 2026 at 03:10 UTC.
| Chairman of the Board & Co-CEO | Feng Zhou (age 33) |
|---|---|
| Chief Financial Officer | Xiaodong Pan (age 47) |
| Executive Director | Jun Zheng (age 48) |
Major Backers & Investors (SXTC)
Notable institutional backers of SXTC include Sabby Management, LLC, according to Nexqual as of June 10, 2026 at 03:10 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Sabby Management, LLC | 8.16% |
Source: Nexqual, June 10, 2026 at 03:10 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RETO | ReTo Eco-Solutions, Inc. | USD 2.29 | ▼ 2.97% |
| AIHS | Senmiao Technology Limited | USD 1.33 | ▲ 15.65% |
| BIMI | BIMI International Medical Inc. | USD 0 | ▲ 0% |
| ADTX | Aditxt, Inc. | USD 0.03 | ▼ 53.39% |
| PHIO | Phio Pharmaceuticals Corp. | USD 1.08 | ▲ 1.89% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:10 UTC. This page is informational and not investment advice.